| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.39 | 0.07 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.37 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |